Interventions Impacting the Natural History of Chronic Plaque Psoriasis
A special issue of Dermato (ISSN 2673-6179).
Deadline for manuscript submissions: 31 May 2024 | Viewed by 654
Special Issue Editors
Interests: psoriasis; clinical dermatology; atopic eczema/dermatitis; venereology
Interests: psoriasis; psoriatic arthritis; atopic dermatitis; metabolic syndrome; vitamin D; alopecia areata; autoimmune bullous diseases; hidradenitis suppurativa; biologic therapy; urticaria
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic plaque psoriasis is not only a cutaneous disease, but a systemic disorder. There is a growing body of epidemiological evidence supporting the associations between psoriasis and cardiometabolic, gastrointestinal, renal, malignancies and mood disorders. The pathogenesis of the intersection of psoriasis and comorbidities is not fully understood. Psoriatic skin produces a broad range of inflammatory cytokines that are released into the systemic circulation and fuel systemic inflammation. Other non-cutaneous sites, including adipose tissue, may contribute to this inflammatory state. Elevated systemic levels of cytokines support asymptomatic inflammation that can cause tissue damage over time. In addition, the natural clinical course of psoriasis has been poorly characterized. The risk of progression from mild to moderate–severe psoriasis is unclear. Identifying prognostic factors that negatively affect the clinical course of psoriasis may provide an important advantage, enabling early therapeutic intervention of patients at risk of worsening disease.
Drawing on experience with other immune-mediated diseases, such as rheumatoid arthritis and Crohn's disease, it has been hypothesized that timely systemic treatment targeting pathogenic cytokines may not only improve skin symptoms but also systemic inflammation. The objective of the Special issue is to collect evidence the impact of interventions on the natural history of plaque psoriasis.
Experimental and observational studies, systematic reviews and meta-analyses and narrative reviews are welcome.
Dr. Francesco Bellinato
Dr. Paolo Gisondi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Dermato is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- psoriasis
- biologics
- disease course
- systemic inflammation
- comorbidities
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
